The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial

Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S75-S75
Hauptverfasser:	Emminger, W, Dahl, R, Kapp, A, Colombo, G, Rak, S, Broge, L, Durham, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Clinical trials Drug therapy Grasses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	S75
container_issue	2
container_start_page	S75
container_title	Journal of allergy and clinical immunology
container_volume	121
creator	Emminger, W Dahl, R Kapp, A Colombo, G Rak, S Broge, L Durham, S
description	Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.
doi_str_mv	10.1016/j.jaci.2007.12.297
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504898576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S009167490702725X</els_id><sourcerecordid>3240026421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2286-7338b29266d1fdf5cc7b4f71ca86640e6256b54057116d664b8a0cfb9b3bdcb43</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhkVpodu0L9CToGe7kmxLdimFsCRpYKGHdaE3IcmjjVzb2kp2wJc-e2U2EMihp2Fm_n9m-Aahj5TklFD-uc97ZVzOCBE5ZTlrxCu0o6QRGa9Z9RrtCGloxkXZvEXvYuxJyou62aG_7QPgg59OWQthxDfWOqPMitXU4aOyMK_YW6zwXVAx4uthgHCCCbdKDzBj6wM-Lnpw02lRA74fx2Xy8wMEdV6_4Fs3dakTsQ1-TDOKbA14n8RpxYDb4NTwHr2xaojw4SleoZ-3N-3-e3b4cXe_vz5khrGaZ6Ioas0axnlHbWcrY4QuraBG1ZyXBDiruK5KUglKeZdKulbEWN3oQndGl8UV-nSZew7-zwJxlr1fwpRWSlqRsm7qSvCkYheVCT7GAFaegxtVWCUlcuMse7lxlhtnSZlMnJPp68UE6f5HB0FG42Ay0LkAZpadd_-3f3thN0-EfsMK8flMGZkk8rg9cvsjEYQJVv0q_gFk35rS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504898576</pqid></control><display><type>article</type><title>The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Emminger, W ; Dahl, R ; Kapp, A ; Colombo, G ; Rak, S ; Broge, L ; Durham, S</creator><creatorcontrib>Emminger, W ; Dahl, R ; Kapp, A ; Colombo, G ; Rak, S ; Broge, L ; Durham, S</creatorcontrib><description>Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2007.12.297</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><subject>Allergy and Immunology ; Clinical trials ; Drug therapy ; Grasses</subject><ispartof>Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S75-S75</ispartof><rights>American Academy of Allergy, Asthma & Immunology</rights><rights>2008 American Academy of Allergy, Asthma & Immunology</rights><rights>Copyright Elsevier Limited Feb 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2286-7338b29266d1fdf5cc7b4f71ca86640e6256b54057116d664b8a0cfb9b3bdcb43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S009167490702725X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Emminger, W</creatorcontrib><creatorcontrib>Dahl, R</creatorcontrib><creatorcontrib>Kapp, A</creatorcontrib><creatorcontrib>Colombo, G</creatorcontrib><creatorcontrib>Rak, S</creatorcontrib><creatorcontrib>Broge, L</creatorcontrib><creatorcontrib>Durham, S</creatorcontrib><title>The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial</title><title>Journal of allergy and clinical immunology</title><description>Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.</description><subject>Allergy and Immunology</subject><subject>Clinical trials</subject><subject>Drug therapy</subject><subject>Grasses</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kcFq3DAQhkVpodu0L9CToGe7kmxLdimFsCRpYKGHdaE3IcmjjVzb2kp2wJc-e2U2EMihp2Fm_n9m-Aahj5TklFD-uc97ZVzOCBE5ZTlrxCu0o6QRGa9Z9RrtCGloxkXZvEXvYuxJyou62aG_7QPgg59OWQthxDfWOqPMitXU4aOyMK_YW6zwXVAx4uthgHCCCbdKDzBj6wM-Lnpw02lRA74fx2Xy8wMEdV6_4Fs3dakTsQ1-TDOKbA14n8RpxYDb4NTwHr2xaojw4SleoZ-3N-3-e3b4cXe_vz5khrGaZ6Ioas0axnlHbWcrY4QuraBG1ZyXBDiruK5KUglKeZdKulbEWN3oQndGl8UV-nSZew7-zwJxlr1fwpRWSlqRsm7qSvCkYheVCT7GAFaegxtVWCUlcuMse7lxlhtnSZlMnJPp68UE6f5HB0FG42Ay0LkAZpadd_-3f3thN0-EfsMK8flMGZkk8rg9cvsjEYQJVv0q_gFk35rS</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Emminger, W</creator><creator>Dahl, R</creator><creator>Kapp, A</creator><creator>Colombo, G</creator><creator>Rak, S</creator><creator>Broge, L</creator><creator>Durham, S</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20080201</creationdate><title>The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial</title><author>Emminger, W ; Dahl, R ; Kapp, A ; Colombo, G ; Rak, S ; Broge, L ; Durham, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2286-7338b29266d1fdf5cc7b4f71ca86640e6256b54057116d664b8a0cfb9b3bdcb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Allergy and Immunology</topic><topic>Clinical trials</topic><topic>Drug therapy</topic><topic>Grasses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Emminger, W</creatorcontrib><creatorcontrib>Dahl, R</creatorcontrib><creatorcontrib>Kapp, A</creatorcontrib><creatorcontrib>Colombo, G</creatorcontrib><creatorcontrib>Rak, S</creatorcontrib><creatorcontrib>Broge, L</creatorcontrib><creatorcontrib>Durham, S</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Emminger, W</au><au>Dahl, R</au><au>Kapp, A</au><au>Colombo, G</au><au>Rak, S</au><au>Broge, L</au><au>Durham, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2008-02-01</date><risdate>2008</risdate><volume>121</volume><issue>2</issue><spage>S75</spage><epage>S75</epage><pages>S75-S75</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2007.12.297</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0091-6749
ispartof	Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S75-S75
issn	0091-6749 1097-6825
language	eng
recordid	cdi_proquest_journals_1504898576
source	Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects	Allergy and Immunology Clinical trials Drug therapy Grasses
title	The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T05%3A24%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Long-Term%20Efficacy%20and%20Safety%20of%20a%20Grass%20Allergen%20Tablet%20for%20Sublingual%20Immunotherapy:%20Findings%20from%20a%203-yr%20Clinical%20Trial&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Emminger,%20W&rft.date=2008-02-01&rft.volume=121&rft.issue=2&rft.spage=S75&rft.epage=S75&rft.pages=S75-S75&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2007.12.297&rft_dat=%3Cproquest_cross%3E3240026421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504898576&rft_id=info:pmid/&rft_els_id=1_s2_0_S009167490702725X&rfr_iscdi=true